Company Overview
Snapshot
Founded in November 2023 by Moshe Safran and Ilya Kovler, XPlan operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on the development of its AI-powered precision arthroplasty technology.
Business overview
XPlan develops AI-powered precision arthroplasty technology for preoperative planning and robotic arthroplasty. Its core product utilizes patent-pending technologies to create 3D models directly from standard X-rays, eliminating the need for costly CT scans and manual 3D segmentation. This innovation targets the healthcare industry, specifically providers, by offering a solution for digital healthcare, medical decision support, and orthopedic surgery.
Log in to access full profile ›Company Intelligence Q&A
- What is XPlan's primary technological focus?
- XPlan focuses on AI-powered precision arthroplasty, utilizing unique, patent-pending technologies for 2D to 3D reconstruction, image calibration, and automated, AI-based implant fitting.
- What problem does XPlan's technology address in medical imaging?
- XPlan's technology addresses the need for 3D modeling in preoperative planning by generating 3D models directly from standard X-rays, thereby eliminating the reliance on costly CT scans and associated reimbursement issues or added costs for hospitals and patients.
- Who are the founders of XPlan?
- XPlan was founded by Moshe Safran, who serves as Co-founder & CEO, and Ilya Kovler, who is the Co-founder & CTO.
- When was XPlan founded?
- XPlan was founded in November 2023.
- What stage of funding is XPlan currently in?
- XPlan is currently in the Pre-Funding stage, indicating it has not yet raised external capital.